('deepligbuilder', 42);('figure', 26);('mcts', 25);('ipa', 16);('rmsd', 13);('btk', 10);('mmd', 9);('information modeling', 9);('phgdh', 8);('structure', 8);('linear', 8);('smarts', 7);('monte carlo', 6);('atpbinding', 6);('smina', 6);('mmff94s', 6);('s1', 6);('mlp', 6);('std wd', 6);('building blocks', 5);('c w', 5);('advanced interdisciplinary studies pekinguniversity beijing', 4);('se3equivariant', 4);('tree search', 4);('new atom', 4);('enamine', 4);('s14', 4);('pdbbind', 4);('wasserstein', 4);('gaussian', 4);('s4', 4);('tanimoto', 4);('nad', 4);('building block', 4);('medicinal chemistry', 4);('cheminformatics', 4);('design journal', 4);('ts', 4);('information', 4);('additionally', 3);('synthetic path', 3);('specically', 3);('synthon dataset', 3);('qvalue', 3);('schrfer', 3);('based', 3);('similar molecules', 3);('eu', 3);('s2', 3);('chemistry', 3);('molecular', 3);('structurebased', 3);('chemical space', 3);('new atoms', 3);('neural network', 3);('zernike', 3);('design 3d molecules', 2);('drug discovery usinggeometric transformersyibo', 2);('lijianfeng peiand luhua laicenter', 2);('chinacenter quantitative biology', 2);('chinabnlms', 2);('chemistry molecular engineering peking', 2);('beijing100871 chinaemail', 2);('dec', 2);('synthesizability constraint', 2);('generative models', 2);('transformer network', 2);('previous methods', 2);('synthons', 2);('synthesizable 3d molecules', 2);('made', 2);('purchasable building blocks', 2);('global stock', 2);('hartenfeller', 2);('reaction steps', 2);('figure s5', 2);('generation scheme', 2);('s13', 2);('new method', 2);('possible actions', 2);('relative 3d positional', 2);('rdkit', 2);('s16', 2);('synthesizable molecules', 2);('dierent model congurations', 2);('molecular weight', 2);('rotatable bonds', 2);('rot', 2);('hba', 2);('qed', 2);('druglikeness lters', 2);('testset molecules', 2);('morgan usrcat', 2);('case', 2);('athe structure', 2);('interaction pattern', 2);('shape fsmina', 2);('molecules gthe', 2);('molecules step', 2);('anity conformation', 2);('cys481', 2);('gdc0853 fenebrutinib', 2);('conditional generative model', 2);('rst row', 2);('qvalues', 2);('pubchem', 2);('novel structures', 2);('asp175', 2);('schottenbaumann', 2);('wittig', 2);('grignard', 2);('relative positional', 2);('mctsbased', 2);('3d molecules', 2);('nature reviews drug discovery', 2);('novo drug', 2);('liu z multiobjective', 2);('novo drug design conditional graphgenerative model journal', 2);('li hu j wang zhou j zhang', 2);('liu z deepscaold comprehensivetool scaoldbased de novo drug discovery', 2);('deep learning', 2);('journal ofchemical', 2);('li pei j lai', 2);('novo drug design', 2);('chemical science', 2);('coley', 2);('molecules', 2);('hartenfeller eberle meier p nietooberhuber', 2);('xiao', 2);('huang r mei j schuurmans muller maximum', 2);('entropy montecarlo planning', 2);('advances neural information processing systems', 2);('bickerton g r paolini g v besnard j muresan hopkins', 2);('quantifyingthe', 2);('chemical beauty drugs', 2);('nature chemistry', 2);('gretton borgwardt k rasch j scholkopf', 2);('smola', 2);('machine learning', 2);('comprehensive guide', 2);('journal ofmedicinal', 2);('previous version', 2);('s12', 2);('ats', 2);('transformer layers', 2);('dense layers', 2);('sdpa ipa', 2);('previous synthons', 2);('softmade', 2);('druglike molecules', 2);('reaction type', 2);('etkdg', 2);('molecules test', 2);('s3', 2);('athe topological structure', 2);('gdc0853', 2);('functional', 2);('grey needs', 2);('network check check', 2);('learningrate decaycheck check', 2);('globallow', 2);('noise scale check check', 2);('models dierent hyperparameterssee', 2);('description conguration report', 2);('standard deviation propertyas', 2);('distance test', 2);('rst row report statistics molecules', 2);('druglikeness lteringmodel variant', 2);('003small noise scale', 2);('sasa polar sasa radius', 2);('3d pair', 2);('international conference', 2);('synthesisdriven', 1);('druglike compounds', 1);('essential drug discoverybut task', 1);('high cost chemical synthesis validation', 1);('withtheiroutstandingperformancein', 1);('years 3d molecule generativemodels', 1);('utilize 3d interactioninformationbetweenthetargetandligand', 1);('itremainschallengingtosynthesizethemoleculesgeneratedbythesemodelslimitingthespeedofbioactivityvalidation structure optimization work', 1);('deepligbuildera', 1);('deep generative model 3d molecules', 1);('novodrug1arxiv230100167v1 qbioqm', 1);('generation framework', 1);('3d molecular structures model', 1);('synthetic pathways', 1);('assists retrosynthetic analysis', 1);('anew way', 1);('ofpurchasable building blocks method', 1);('high scalability compatiblewith', 1);('btk nad', 1);('forcase studies', 1);('desirable interaction modes', 1);('apowerful tool', 1);('process drug discovery', 1);('important step', 1);('designsynthesisevaluation workow moleculedesign1', 1);('introductionthe', 1);('high nancial cost', 1);('low success rate drug discovery place', 1);('tremendous challengesin', 1);('important diseases1to address', 1);('promising compounds', 1);('vast space chemicalstructures', 1);('subsequent biological validation', 1);('computational', 1);('vs', 1);('lters chemical libraries', 1);('favorable compounds spite success', 1);('bioactive molecules3vs', 1);('library uses', 1);('small', 1);('coverage chemical spaceand', 1);('large ones impose high computational costs', 1);('software hardware platforms4de novo drug design uses computationalalgorithms generate molecule structures scratch5provides option explore new2chemical space', 1);('compoundsover decades variety', 1);('novo drug design programs', 1);('legend6ludi7concepts8and ligbuilder911many', 1);('todesign bioactive molecules', 1);('successful experimental validation1216in', 1);('recent years', 1);('molecule generative models', 1);('new class', 1);('promising methods', 1);('deep learning models', 1);('desirable molecule structures training data', 1);('need manualintervention contrasts', 1);('novo design programs whichin general', 1);('extensive eorts design search rules', 1);('theadvantages', 1);('deep generative models', 1);('spawn series research', 1);('toutilize drug discovery', 1);('dierent molecule representations', 1);('smiles18and', 1);('molecular graph1921to', 1);('various trainingmethods', 1);('vae22gan2324and rl2526as', 1);('wide range models', 1);('various issues', 1);('drug design', 1);('molecular properties22pharmacophores27scaolds28and targets29most', 1);('generative models molecules', 1);('2d topological chemical structures foundation bioactivity', 1);('interactions 3d structures targets ligands', 1);('directly', 1);('3d molecules insidethe target', 1);('utilize interaction', 1);('novelty benets', 1);('attention developing3d generative models molecules', 1);('target information', 1);('approaches includemodels', 1);('3d pocket information', 1);('smiles', 1);('ligann30andthe', 1);('rnn', 1);('xu', 1);('structure contains topological information order', 1);('generate 3d structures', 1);('masuda', 1);('ligan uses', 1);('vae', 1);('3dcnn generate', 1);('atomic density grids andlater', 1);('grids 3d molecules', 1);('conversion dierent represen3tations', 1);('deepligbuilder33to', 1);('3d molecules insidepockets', 1);('graph generative models', 1);('tree search graph generative models', 1);('pocket2mol34use', 1);('equivariant networks encode pocket informationas conditional inputs', 1);('recent works', 1);('diusion models 3dmolecule generation', 1);('dilinker35which', 1);('permutation invariant way ofgeneration', 1);('autoregressive modelsdespite progress', 1);('chemical synthesis acommon', 1);('step medicinal chemistry research', 1);('novo design programsare', 1);('compound library', 1);('methods proposemolecules', 1);('challenging synthesize', 1);('experimental validation dicult solution problem use syntheticallyaware models37those models generate molecules', 1);('explicit building blocks chemical reactions approaches relativelycommon', 1);('novo design programs', 1);('synopsis38and dogs39but', 1);('deep learning methods', 1);('number ofmodels', 1);('generative networks', 1);('moleculechef40dogae doggen41pgfs42and synnet43those', 1);('methods haveshown', 1);('promising results', 1);('2d molecule design', 1);('recent 3d generative models', 1);('basedon', 1);('deep generativemodel', 1);('3d molecule design', 1);('molecules work', 1);('learning synthesizability constraints', 1);('novo drug design program', 1);('deepligbuilder theprogram', 1);('druglike molecules thesame time', 1);('3d conformations', 1);('structurebaseddesign tasks', 1);('transformer network generate 3d molecular graphs4atombyatom step mask', 1);('inappropriate atom bond types theaction space output structure', 1);('reactant dataset', 1);('synthons order incorporate 3d pocket information', 1);('pharmacophore shapeinformation', 1);('reinforcement learning module', 1);('drug design applications', 1);('design inhibitors', 1);('brutons', 1);('nadbinding', 1);('pocket human phosphoglycerate dehydrogenase', 1);('methodsin', 1);('brief account architecture', 1);('implementation details', 1);('supplementary methods sections1to', 1);('ensure high synthetic accessibility', 1);('generates molecules', 1);('reactant time', 1);('corresponding reaction rulesunlike', 1);('generates 3d conformation moleculefor', 1);('design tasks', 1);('large conformational changes', 1);('3d structures reactants', 1);('deepligbuilderrst', 1);('generates synthon structures', 1);('corresponding reactants asshown', 1);('hypothetical reactants', 1);('openvalences specic reactivity reactant', 1);('synthon extractingthe substructure product', 1);('reactant way', 1);('anew synthon molecule aect conformation', 1);('previous synthons making5figure', 1);('synthons f', 1);('synthon modeladopts', 1);('generation scheme e', 1);('edits molecular graph', 1);('new nodes atoms edges bonds decisions', 1);('transformer network ae encoders', 1);('process input information', 1);('generation tasksthe encoder', 1);('shape b pharmacophore', 1);('inputs decoder euses input information', 1);('blocks output distribution action space applyaction masks step constrain generation trajectory producessynthons', 1);('synthetic route', 1);('explicit reactants reaction typesg6it', 1);('suitable 3d generation tasks work use', 1);('enaminebuilding', 1);('blocks reactant', 1);('al44each product molecule', 1);('detailsrelated', 1);('s11when', 1);('synthon structure', 1);('similar toour', 1);('synthon structure 3d graph itis', 1);('graph structure step model eitheradds', 1);('new bond performs operations', 1);('wealso', 1);('various improvements', 1);('previous method', 1);('treatment ring generation', 1);('ring structuredeepligbuilder rst specify size ring', 1);('location ring', 1);('generation process', 1);('potential issues whenthe user changes synthon dataset', 1);('s12duringgeneration', 1);('action space thatthe', 1);('purchasable synthons mask', 1);('prex tree synthon structures', 1);('building blockdataset', 1);('chemical constraintsoers', 1);('previous approaches4143which', 1);('entire set building blocks generate', 1);('actiondeepligbuilderusesanse3equivarianttransformertodecidewhichactiontoperformat step generation', 1);('3d molecular graph sequenceof actions', 1);('generate structure', 1);('equivalent concept ofa sentence', 1);('nlprelated', 1);('correspondingly', 1);('word thesentence', 1);('thenetworkadoptsanencoderdecoderarchitecture', 1);('whichisusedtotranslatetheinput information', 1);('synthons pharmacophores discussed7figure', 1);('structurebasedmolecule generation', 1);('pocket structure search', 1);('seedatom gure use', 1);('example eachstep model rst', 1);('promising node lookahead tree b expandsthe tree', 1);('3d molecule cnext model', 1);('state uses conditional transformer performthe rollout', 1);('score thereward', 1);('parent nodes update', 1);('estimates ebelow', 1);('new synthon structures', 1);('incorporate 3d informationin equivariant manner attach 3d', 1);('atom aftereach action use invariant point attention', 1);('ipa45to', 1);('communicate information betweenactions', 1);('express spatial relationshipbetween action pairs network training', 1);('3d structures', 1);('train model information', 1);('s15to', 1);('introduce 3d information targets', 1);('usedalgorithm reinforcement learning', 1);('optimize molecule structure', 1);('search method', 1);('ments46with', 1);('reward function', 1);('score47the generated3d pose', 1);('step8toenhancetheperformanceofmctswedevelopedapharmacophoreandshapeconditionedtransformer rollout policy', 1);('pharmacophore', 1);('bioactivity ligands', 1);('drug design48shape information', 1);('geometry pocket information', 1);('model training dataset ofpharmacophoreligand pairs', 1);('synthesizable 3d molecules pharmacophore', 1);('ligands section', 1);('s15', 1);('conditional rolloutpolicy oers signicant speed ups', 1);('results31 performance', 1);('unconditional generative modelwe rst', 1);('performance transformer network unconditional settingin manner', 1);('valid 3d structures', 1);('severalgenerated', 1);('molecules network', 1);('figure s6', 1);('visual inspection thesemolecules', 1);('reasonable 3d conformations', 1);('local geometries', 1);('hybridization state', 1);('atomic environments', 1);('neighborsof', 1);('sp3atoms form tetrahedron structures', 1);('alsothe', 1);('overall conformations', 1);('signicant clashes', 1);('thoseobservations', 1);('quantitative evaluation metrics', 1);('section 313deepligbuilder', 1);('unique synthetic paths', 1);('moleculealong 3d structures', 1);('structure1 whichcontainsexplicitpurchasablereactantswithenamineids', 1);('inthisway', 1);('performance unconditional generative network abthe distributionof', 1);('qed sasa', 1);('red testset grey molecules cthe distribution molecular shape da visualization thedistribution 2d', 1);('morgan', 1);('redand test', 1);('grey molecules', 1);('boxes', 1);('show locations', 1);('nondruglike molecules', 1);('ethe 2d', 1);('negative logscale', 1);('shows thevalues', 1);('molecules fthe', 1);('values generatedmolecules', 1);('values forconformers', 1);('etkdg10of', 1);('wetlab evaluations molecules311', 1);('distribution', 1);('2d 3d molecular propertiesto', 1);('desirable druglikeproperties10000structuresaresampledfromthemodelandseveralimportant2dpropertiesare', 1);('molecule properties', 1);('logp', 1);('hydrogen bond donors', 1);('hbd', 1);('metric druglikeness estimation distributions thoseproperties', 1);('figure s7 figure', 1);('distribution ofmost properties matches', 1);('blue test', 1);('molecules grey', 1);('amajority', 1);('figure3a', 1);('high druglikenesswe', 1);('result molecules', 1);('red general property distribution', 1);('molecules diers', 1);('druglike test', 1);('withhigh molecular weight', 1);('low druglikeness oer quantitative evaluation wecalculate sum', 1);('standard deviation statistics', 1);('s2 mathematically', 1);('approximations twodistributions property distributions', 1);('similarto druglike test', 1);('thatthe model', 1);('enrich druglike', 1);('3d molecular descriptors', 1);('methods abilityto model 3d properties', 1);('figure s7', 1);('gishows distribution solventaccessible surface areas', 1);('sasa50 polar sasa', 1);('radius gyration', 1);('rg51', 1);('2d case', 1);('shape distribution', 1);('pmi', 1);('nprs52', 1);('linear region', 1);('distribution test', 1);('randomly', 1);('verydierent distribution 3d properties quantitative measurements', 1);('tables3', 1);('conrm molecules', 1);('model share', 1);('similarity 3d propertieswith validation test', 1);('ones312 ability model', 1);('model druglike chemical spaceto access networks ability model druglike space', 1);('synthesizable molecules wevisualize distribution 2d 3d structures', 1);('figure s8 morgan usrcat53ngerprints', 1);('areusedtorepresent2dand3dmoleculestructuresandtsne54isusedfordimensionreductionthe gures', 1);('overall distribution matches', 1);('blueand test', 1);('grey molecules hand regions', 1);('locationsin chemical space', 1);('low druglikenessto oer quantitative evaluation use', 1);('mmd55to', 1);('measure overlap chemical space', 1);('inprevious works2833mmd metric', 1);('probability distributions', 1);('ngerprints representationsfor', 1);('calculation 2d 3d chemical space', 1);('andfigure 3e', 1);('similarityto test', 1);('conclude training network enrich output tothe druglike portion chemical space12313 quality', 1);('3d structuresan', 1);('important aspect models performance ability generate', 1);('valid 3d structuresof molecules evaluation rst measure ability', 1);('model distributionof torsion angles dierent environments environments', 1);('torsionsmarts patterns', 1);('torsion distribution', 1);('testset molecules environment', 1);('rank value fromlowesttohighest asshowninfigure3 g', 1);('sincetheexactvalueofmmdlacksinterpretabilitywe', 1);('inspect torsion distribution environment', 1);('lowestmmd values', 1);('show good', 1);('case thehighest', 1);('construct local geometriesof moleculesnext', 1);('global conformation quality', 1);('forceeld average', 1);('s4 figure', 1);('f distribution', 1);('figure s9 conformations', 1);('values average 069as reference', 1);('value relaxation conformations', 1);('etkdgusing', 1);('topological structures', 1);('etkdgis', 1);('conformation generation method', 1);('distance geometry empirical distribution torsion angles method', 1);('btks atpbindingpocketas', 1);('3d molecule designby', 1);('mcts todemonstrate', 1);('performance use', 1);('design inhibitors bind the13figure', 1);('kinase domain', 1);('gdc0853 fenebrutinibbthe', 1);('gdc0853 atpbinding', 1);('cthepharmacophore shape condition', 1);('asthe seed atom', 1);('molecule growth dfthe distribution dthe similarity thegiven pharmacophore ethe similarity', 1);('scores insidethe', 1);('rewards amongall', 1);('grey andthat', 1);('btk brutons', 1);('tyrosine kinase', 1);('important roles thesignal transmission', 1);('bcells57and', 1);('bcellmalignancies58and', 1);('autoimmune diseases59due importance variety compoundshave', 1);('pocket severalof', 1);('clinical use60however', 1);('inhibitors bind', 1);('btkcovalently', 1);('otarget eects', 1);('kinases withcys481like residues61resistant mutations', 1);('clinical eect62noncovalentbinderscanintheoryavoidthosedisadvantages andinthissection weattemptto', 1);('design noncovalent', 1);('inhibitorsseveral noncovalent', 1);('clinical investigation', 1);('herewe', 1);('extract pharmacophore', 1);('attempt use', 1);('generate newmolecules novel structures', 1);('ashows structure kinase domain ofbtk', 1);('pdb id', 1);('clinical trial63gdc0853 utilizes', 1);('important interactions', 1);('site hydrogen', 1);('met477 lys430', 1);('hydrophobic interactions hinge region selectivity pocketh3', 1);('information construct shape pharmacophore information', 1);('c use condition', 1);('deepligbuildernote gdc0853', 1);('figure4b', 1);('constrain output moleculeto', 1);('size leadlike', 1);('theoxygen', 1);('atom carbonyl group', 1);('seed molecule growth', 1);('met477after', 1);('molecule design detailsshown section', 1);('model enrich molecules basedon', 1);('deshows conditional model generate molecules15with', 1);('pharmacophore shape', 1);('unconditional methodsnext', 1);('conditional rollout', 1);('mcts figure', 1);('theconditional rollout', 1);('benet usingmcts', 1);('conditional model', 1);('fshows thatmcts', 1);('oers enrichment range high', 1);('smina score', 1);('kcalmol value', 1);('conditional networkto', 1);('molecule optimization process visualize search', 1);('mcts figure s10', 1);('space constraints tree contains states therst synthon nodes visit', 1);('themodel prioritizes', 1);('side tree', 1);('favoreddue reasons', 1);('bad 3d positions synthon anchors', 1);('figure s10several', 1);('hj search', 1);('chembldatabase', 1);('btk thetopological', 1);('similarity seed molecule', 1);('gdc0853 figure', 1);('c alsolow contrast terms pharmacophore shape input pharmacophore featuresare', 1);('lys430', 1);('andmet477 hydrophobic interactions', 1);('ends molecule', 1);('synthesis', 1);('molecule making retrosyntheticanalysis', 1);('figure s12', 1);('pharmacophore constraint33', 1);('phgdhtargeting', 1);('cancer metabolism', 1);('important strategy cancer drug development64human phosphoglycerate dehydrogenase', 1);('key enzyme serinebiosynthesis pathway', 1);('crucial roles', 1);('designinhibitors bind', 1);('nadpocket multiple', 1);('previous works', 1);('scaold case study weuse', 1);('design potential binders', 1);('pocket novel structuresfigure 5ashows structure', 1);('phgdh pdb id', 1);('compound 15a', 1);('potent inhibitor target', 1);('mullarky', 1);('al66figure 5bdemonstrates theinteraction ligand target nitrogen atom amide group incompound 15acts hydrogen bond donor interacts', 1);('carboxylgroup compound 15can form hydrogen bonds backbone nitrogen atoms alsoforms chargecharge interaction', 1);('arg155', 1);('indole structure compound 15residesinside hydrophobic region', 1);('orange arrow', 1);('b pharmacophoremodel', 1);('c use amidestructure seed molecule growth', 1);('figure s13', 1);('theshape', 1);('compound 15is', 1);('input featurenext use', 1);('generate molecules', 1);('pharmacophore andshape information target structure', 1);('similar previous section rst evaluatewhether conditional model oers', 1);('deshows molecules', 1);('conditional transformer17figure', 1);('compound 15bthe interaction betweencompound 15with', 1);('cthe pharmacophore andshape condition', 1);('seed atom', 1);('formolecule growth dfthe distribution dthe similarity', 1);('pharmacophoreethe similarity', 1);('generatedmolecules step', 1);('input pharmacophorefigure', 1);('withthe unconditional model', 1);('gshows introduction conditions', 1);('blue curve', 1);('benet themcts module', 1);('model generate molecules', 1);('pharmacophore shape matches', 1);('dockingscore result average improvement', 1);('mcts smina', 1);('conditional modelfigure 5hjshows', 1);('anity reaction paths', 1);('low topological similarities compound', 1);('hydrogen bond donors interact', 1);('acceptors interact', 1);('ile156 arg155', 1);('results withhigh topological similarity molecules', 1);('chembl', 1);('compound records', 1);('similar moleculesare', 1);('phgdh interestingly', 1);('similar oxetane structure compound', 1);('structural motifhelps form', 1);('molecule shape', 1);('accommodation pocket andalso creates hydrophobic interaction', 1);('ile17734 ablation', 1);('studies eects dierent hyperparametersit', 1);('dierent architectural hyperparameter choices aectthe performance ofthe', 1);('model section demonstratethe impact severalimportant network', 1);('details', 1);('congurations exploredare', 1);('performances model dierent congurations areshown', 1);('s419figure', 1);('athe synthetic path', 1);('involves atwostep process rst connects amide bond', 1);('reactionand forms double bond', 1);('enamine ids', 1);('reactants arealso', 1);('additional activationstep transforms carboxyl group acyl chloride', 1);('reactionrequires formation ylide bthe synthetic path', 1);('bydeepligbuilder rst', 1);('thethird', 1);('urea structure', 1);('amine group theisocyanate group', 1);('rst step reactant', 1);('amine group reactant', 1);('grey needs tobe', 1);('reactions20341 eect', 1);('accessible building blocksa major', 1);('synthetic paths accessible building blocks', 1);('accessibility buildingblocks', 1);('technical advances numberof', 1);('synthesizable building blocks', 1);('years hand instock', 1);('times locations requireondemand synthesis', 1);('ts need', 1);('retraininghere simulate scenarios', 1);('choice building blocks impacts thequality', 1);('moleculesto simulate lack instock availability', 1);('certain building blocks', 1);('compounds termsof quality topological structures', 1);('eshows increasein', 1);('value restriction', 1);('molecules stillmaintain high druglikeness average', 1);('building blocks terms quality 3d conformation', 1);('andfigure 3findicates increase', 1);('than1 results', 1);('indeedimpact performance network eect', 1);('forregular application', 1);('drug design tasksthen', 1);('aect generationresult', 1);('comprehensive catalog contains', 1);('efshows thatthis', 1);('impact performance output', 1);('inconclusion', 1);('promising performance building block', 1);('blocks21342 eect dierent ways encode 3d structural informationbesides', 1);('module incorporate 3d informationdeepligbuilder', 1);('uses invariant point attention', 1);('oers geometricallyaware way pass information atoms', 1);('ipawe', 1);('impact changes', 1);('theresults', 1);('impacton quality 3d conformation', 1);('3d structure quality', 1);('quality 2d structure', 1);('3d positional', 1);('observe asignicant improvement 2d structural quality', 1);('0718the results', 1);('tradeo 2d 3d structural quality andthat', 1);('3d information', 1);('havedierent emphases', 1);('result view', 1);('geometric information', 1);('previous work', 1);('2d structures', 1);('relies onaccurate 3d information', 1);('reduces models ability', 1);('errors duringgeneration33the', 1);('way communicate 3d information', 1);('act asa form regularization model uses 3d information handthere limitation 3d', 1);('accurate 3d structures', 1);('ipaa', 1);('lack regularization', 1);('quality 2d structures', 1);('modules actsas compromise', 1);('3d conformation quality', 1);('2d structurequality224', 1);('conclusionwe', 1);('novo drug design tool', 1);('generatessynthesisdriven 3d molecules', 1);('uses geometric transformer', 1);('reinforcement learning module navigate spaceof', 1);('synthesizable 3d molecules identify potential bioactive compounds method aimsto address', 1);('deep molecule generative models', 1);('design of3d molecules', 1);('3d constraints', 1);('design molecules', 1);('promising performances', 1);('druglikeness andgeometric quality synthetic accessibility constraint case study relatedto', 1);('btk phgdh deepligbuilder', 1);('enriches molecules', 1);('favorable interaction patterns target pocket', 1);('synthetic route withexplicit reactions building blocks', 1);('supplier makingretrosynthetic analysis', 1);('recent developments 3d generative networks33and idea', 1);('novo design37to', 1);('model chemicalspaceofsynthesizablemolecules wedevelopamethodthatcalculatesastepwiseconstraintofthegeneration trajectorytoensure thatitleads', 1);('compared', 1);('toother approaches', 1);('generation scheme method theorybe', 1);('molecule generative models addition oers betterscalability', 1);('large building block datasets', 1);('full database scans step', 1);('new dataset pharmacophoreligand pairs', 1);('largescale 3d alignment ofmolecules', 1);('on3d information network', 1);('rollout policy', 1);('combination results signicant improvement search speed23of', 1);('mctsdeepligbuilder', 1);('aspects future', 1);('thepresent molecule', 1);('process relies', 1);('limitedin precision planning', 1);('model yield selectivity prediction', 1);('molecules themodel', 1);('update reaction', 1);('broader modernreactions addition', 1);('current version', 1);('seedstructures molecule growth planning', 1);('methods automate', 1);('selection process', 1);('transformer model', 1);('3d pocket structure', 1);('need pharmacophore extraction', 1);('insummary', 1);('due unique capability', 1);('synthesizable molecules 3dstructures', 1);('powerful tool generate bioactive molecules andto accelerate process', 1);('drug design5', 1);('acknowledgementsthis', 1);('national natural science foundation', 1);('china22033001', 1);('yuhao ren kangjie lin', 1);('kind advice onthe synthetic accessbility', 1);('alibaba cloud', 1);('eflops', 1);('computation platform', 1);('gpubased', 1);('network trainingreferences1', 1);('paul mytelka dunwiddie', 1);('persinger', 1);('c c', 1);('munos', 1);('h lindborg r schacht', 1);('rd', 1);('productivity pharmaceuticalindustrys', 1);('grand challenge', 1);('trott olson j autodock vina improving', 1);('speed accuracy docking24with', 1);('function ecient optimization', 1);('journal ofcomputational', 1);('lyu j wang balius e singh levit moroz omeara jche algaa e tolmachova k tolmachev shoichet', 1);('k roth', 1);('lirwin j j ultralarge', 1);('new chemotypes', 1);('nature2019566', 1);('gorgulla', 1);('boeszoermenyi wang zf fischer p coote p', 1);('das km p malets radchenko moroz scott fackeldey khomann iavniuk wagner g arthanari h', 1);('opensource drug discoveryplatform', 1);('ultralarge virtual screens', 1);('nature2020580', 1);('schneider g fechner u computerbased', 1);('novo design druglike molecules', 1);('nishibata itai automatic', 1);('creation drug candidate structures', 1);('receptor structure', 1);('point articial lead generation', 1);('tetrahedron', 1);('bhm hj', 1);('computer program', 1);('ludi', 1);('novo design ofenzyme inhibitors journal', 1);('computeraided molecular', 1);('pearlman murcko concepts', 1);('new dynamic algorithm', 1);('novodrug suggestion journal', 1);('computational chemistry', 1);('wang r gao lai', 1);('ligbuilder multipurpose program structurebaseddrug', 1);('yuan pei j lai', 1);('ligbuilder', 1);('practical', 1);('approachjournal', 1);('yuany peij lailligbuilderv3 amultitargetdenovodrugdesignapproachfrontiers chemistry', 1);('schneider g designing', 1);('future journal', 1);('computeraided moleculardesign201226', 1);('schneider g clark e automated de novo drug', 1);('thereyet angewandte chemie', 1);('edition', 1);('ni yuan huang j mao x lv zhu j shen x pei j lai ljiang h li j discovering potent small molecule inhibitors cyclophilin usingde novo drug', 1);('approach', 1);('shang e yuan chen x liu pei j lai', 1);('de novo', 1);('multitargetligandswithaniterativefragmentgrowingstrategy', 1);('informationand modeling', 1);('h hong kim j hong discovery picomolar abl kinase inhibitorsequipotent', 1);('type t315i mutant', 1);('novo designjournal', 1);('american chemical society', 1);('xu lin k wang wang', 1);('cai', 1);('c song', 1);('c lai', 1);('pei j deep', 1);('learningfor molecular generation', 1);('segler h kogej tyrchan', 1);('waller p generating focused moleculelibraries drug discovery recurrent neural networks acs', 1);('science20174', 1);('li zhang', 1);('jinw barzilayr jaakkolatjunctiontreevariationalautoencoderformoleculargraph generation', 1);('arxiv2018 httpsarxivorgabs1802043642621', 1);('j ying r ren x hamilton', 1);('w l', 1);('leskovec j graphrnn generatingrealistic graphs deep autoregressive', 1);('models arxiv201822', 1);('gmezbombarelli r wei j n duvenaud hernndezlobato j snchezlengeling', 1);('sheberla aguileraiparraguirre j hirzel adams r paspuruguzik automatic', 1);('chemical design', 1);('datadriven continuous representation molecules acs', 1);('central science', 1);('guimaraes g', 1);('sanchezlengeling', 1);('outeiral', 1);('farias p', 1);('l c', 1);('aspuruguzik objectivereinforced generative adversarial networks organ sequence generation', 1);('models arxiv2017 httpsarxivorgabs17051084324', 1);('cao n kipf molgan', 1);('implicit generative model', 1);('small molecular graphsarxiv2018 httpsarxivorgabs18051197325', 1);('olivecrona blaschke engkvist chen h molecular', 1);('denovo design throughdeep reinforcement learning journal', 1);('j liu', 1);('ying r pande v leskovec j graph convolutionalpolicy network goaldirected molecular graph generation', 1);('imrief bradleyar schaarmvd deanecmdeepgenerativemodelsfor3dlinker', 1);('zhavoronkovaetaldeeplearningenablesrapididenticationofpotentddr1kinaseinhibitors nature biotechnology', 1);('skalic sabbadin sattarov', 1);('sciabola fabritiis g targetto drug generative modeling multimodal structurebased ligand designmolecular pharmaceutics', 1);('xum ran chenhdenovo moleculedesignthroughthemolecular generativemodel conditioned', 1);('information protein binding sites', 1);('chemicalinformation modeling', 1);('masuda ragoza koes r generating', 1);('molecular structures conditional receptor binding site deep generative', 1);('models arxiv2020httpsarxivorgabs20101444233', 1);('peng x luo guan j xie q peng j j pocket2mol ecient molecularsampling based', 1);('protein pockets', 1);('igashov strk h vignac', 1);('satorras v g frossard p welling bronsteinm correiabequivariant3dconditionaldiusionmodelsformolecularlinkerdesign', 1);('gao', 1);('synthesizability molecules proposed generativemodels', 1);('dening exploring', 1);('spaces trends chemistry', 1);('vinkers h jonge r daeyaert', 1);('f f', 1);('heeres j koymans', 1);('hlenthejhv lewipj timmermanh akenkv janssenpajsynopsissynthesize optimize', 1);('silico', 1);('hartenfeller zettl h walter rupp reisen', 1);('proschak e weggen sstark h schneider g dogs reactiondriven', 1);('novo design', 1);('bioactive compounds plos computational biology', 1);('bradshaw j paige', 1);('kusner j segler h hernndezlobato j amodel search', 1);('bradshawj paigeb kusnermj seglermh hernandezlobatojmbarkingup', 1);('right tree approach search molecule synthesis', 1);('dags', 1);('arxiv preprintarxiv201211522', 1);('gottipati k sattarov', 1);('niu pathak wei h liu thomas km j blackburn coley', 1);('tang j chandar bengio learning tonavigate synthetically accessible', 1);('reinforcement learningarxiv202043 gao', 1);('mercado r coley', 1);('amortized tree generation bottomup synthesis', 1);('design arxiv202144', 1);('altmann kh schneider g jacoby e renner collection robust organic synthesis reactions', 1);('silico molecule', 1);('jumper j', 1);('highly', 1);('accurate protein structure prediction', 1);('alphafold nature2021596', 1);('koes r baumgartner p camacho', 1);('j lessons learned empirical scoringwith', 1);('csar', 1);('benchmarking exercise', 1);('giordano biancaniello', 1);('argenio facchiano drug', 1);('pharmacophore virtual screening approach pharmaceuticals', 1);('mitternacht freesasa', 1);('open source c library solvent accessible surface areacalculations', 1);('f1000research', 1);('todeschini r consonni v descriptors molecular geometry', 1);('sauer', 1);('schwarz k molecular shape diversity combinatorial librariesa prerequisite broad bioactivity', 1);('information computersciences200343', 1);('schreyer blundell usrcat', 1);('realtime ultrafast shape recognition withpharmacophoric constraints journal', 1);('maatenlvd hintongvisualizingdatausingtsne', 1);('journal machine learningresearch20089', 1);('kernel twosample test journal', 1);('schulzgasch ehrlich hc guba', 1);('rarey stahl torsionangle preferences druglike', 1);('satterthwaite', 1);('li z witte n btk', 1);('function b cell development andresponse', 1);('seminars immunology', 1);('singh p dammeijer', 1);('hendriks r', 1);('role brutons', 1);('tyrosine kinase b cellsand malignancies', 1);('zhang gong h meng', 1);('recent advances btk inhibitors treatmentof inammatory autoimmune diseases molecules', 1);('tasso', 1);('spallarossa russo e brullo', 1);('c development', 1);('btk inhibitorsa fiveyear update molecules', 1);('sibaud v beylotbarry protin', 1);('vigarios e recher', 1);('ysebaert', 1);('dermatological toxicities brutons tyrosine kinase inhibitors', 1);('american journal ofclinical', 1);('dermatology', 1);('woyach j', 1);('resistance mechanisms brutons tyrosine kinase inhibitoribrutinib', 1);('england', 1);('medicine', 1);('crawford j j', 1);('discovery gdc0853 potent selective noncovalentbrutonstyrosinekinaseinhibitorinearlyclinicaldevelopment', 1);('medicinalchemistry', 1);('faubert', 1);('solmonson deberardinis r j metabolic', 1);('science202036865 zhao jy feng kr wang', 1);('zhang jw cheng j', 1);('lin gq gao dtian p retrospective overview phgdh inhibitors regulating cancermetabolism', 1);('european journal', 1);('mullarkyeetalinhibitionof3phosphoglyceratedehydrogenasephgdhbyindoleamides abrogates', 1);('serine synthesis', 1);('cells bioorganic medicinalchemistry', 1);('informationsynthesisdriven', 1);('jfpeipkueducn lhlaipkueducn1', 1);('supplementary methods11 constructing', 1);('synthon datasetwe use building block', 1);('purchasable reactantsthe', 1);('global stock contains', 1);('compounds time access', 1);('july', 1);('availablereactants models performance', 1);('stock comprehensivecatalog contains', 1);('oct', 1);('2022s1arxiv230100167v1 qbioqm', 1);('2022for reactions', 1);('robust chemical reactions relevant drug design', 1);('reactants synthons conversionis', 1);('building block reaction rule', 1);('product structure usingrdkit', 1);('ifthereactioninvolvestworeactants', 1);('function group2 substructure product molecule corresponds building block', 1);('open valences', 1);('reaction type role reaction3 substructure extraction results', 1);('multiple valences', 1);('new ringsare', 1);('reaction case', 1);('new ring structureinside synthon', 1);('ring synthon', 1);('corresponding reactanta visual demonstration process', 1);('figure s1 figure s2', 1);('simplifythe generative model', 1);('reaction result', 1);('open valencein synthon structures valence', 1);('correspond single bond productmolecule reactions', 1);('requirement result', 1);('reactants synthonsthe', 1);('foreach', 1);('building block enumerate', 1);('possible synthon structures', 1);('thereaction rules', 1);('reactant ensurethat', 1);('synthons fragmentlike relevent drug discovery', 1);('rules lter results1', 1);('element', 1);('types atoms', 1);('n p fcl br', 1);('bond types', 1);('double triple aromatic bondss22', 1);('ro2s23', 1);('rings size ring largerthan', 1);('noncovalent binders lter structures thepotential', 1);('covalent bonds protein', 1);('results dataset', 1);('global stock103385 synthons', 1);('comprehensive catalogthe synthons', 1);('moleculessee section', 1);('s1512 performing', 1);('molecule generationdeepligbuilder generates 3d molecules', 1);('method molecule iscomposedof3synthonstructureswhichisequivalenttocombiningthreebuildingblockswithtwo reaction steps', 1);('uses graphbasedapproach', 1);('model generates 3d synthon structures', 1);('molecular graphs', 1);('output graph', 1);('g veabx', 1);('nodes atoms edges bonds', 1);('aavvvandbbuvuveare', 1);('type atom bond', 1);('xxvvvarethe', 1);('3d coordinates atomwhen', 1);('synthon model', 1);('empty graph', 1);('g0', 1);('updates structure', 1);('gtatgt1', 1);('outputs graph', 1);('new synthonfragment', 1);('additional information', 1);('eachnode graph record generation history includes1', 1);('vt wheretrepresents step', 1);('id', 1);('similar previous workss4briey edits tos3the molecular graph', 1);('new bonds', 1);('focusednode2 parent node', 1);('ptpvvvt', 1);('node vis', 1);('parentchild relationshipinduces', 1);('tree molecular graph', 1);('gt', 1);('distances atoms nodes graph input', 1);('thetransformer network', 1);('s14we', 1);('state molecular graph step twith', 1);('additional information asgprimet', 1);('vtetatbtxtvtpt', 1);('graph structure', 1);('types actions', 1);('initialization', 1);('rst atom molecular graph2', 1);('append', 1);('new bond thisaction model needs', 1);('new atom bond', 1);('position model uses sphericalcoordinate frame', 1);('previous works4besidesthe element type', 1);('new atom model', 1);('willbe branches atom', 1);('atom target', 1);('future ring closuresimilar', 1);('ahn', 1);('backtracking', 1);('generation terminates', 1);('node parents4', 1);('search', 1);('loop target action', 1);('new ring', 1);('suitabletarget ring closure network generate action', 1);('multiple timesuntil', 1);('suitable target', 1);('ring closures45', 1);('startloop thisactionhappensafterasearchlooptarget', 1);('actionwhentheappropriatetarget ring closure', 1);('action model determines size', 1);('action series append actions', 1);('model tocomplete ring formation6', 1);('close', 1);('loop action', 1);('ring atoms', 1);('ring target atom', 1);('search looptarget step model', 1);('type bond', 1);('ring thisactionthe process molecule generation', 1);('nite state machine asshown', 1);('figure s3', 1);('full path', 1);('example molecule', 1);('figure s4a', 1);('major dierence generation scheme', 1);('deepligbuilders4is', 1);('emphasis ring generation', 1);('explicit ring structures', 1);('size ring aswell location ring', 1);('processof ring generation', 1);('problems user changes synthondataset', 1);('figure s513 constraining', 1);('model generate structures', 1);('synthon databaseto ensure synthetic accessibility synthons', 1);('basic units molecule generation', 1);('neural networks parametrize', 1);('functions lter reactant dataset forappropriate candidates generation step work', 1);('different approach', 1);('basic generation units building foundation', 1);('previous workss4s6to ens5force constraints chemical space', 1);('masks action space step ofgeneration ensure output topological structure', 1);('thesynthon datasetnext show action masks', 1);('eachsynthon synthon database ss', 1);('list actions', 1);('generate molecular graph', 1);('a1ats denitionof action space generation process', 1);('needto constrain topological structures 3d action information position newatoms', 1);('action space convenience', 1);('action sequencesas trajectories', 1);('synthon dataset acollection trajectories', 1);('ssst sto ensure synthons', 1);('model lie need ensure generationtrajectories lie', 1);('generation history t1t1 a1at1 order ensure nal trajectory lie', 1);('need tomake', 1);('action atis', 1);('following setatats aprimets st prime1t tait', 1);('step guaranteethat', 1);('thetrajectories intsare', 1);('prex tree', 1);('tree node representsa prex trajectory', 1);('action retrievalwe descend tree nd node equals', 1);('outgoing edgesit', 1);('edges form', 1);('way construct actionmasks step ensure', 1);('synthon datasetas method constrain chemical space generative model method hassome advantages', 1);('previous methodss61 complexity', 1);('synthon scale size synthondataset', 1);('searching', 1);('prex tree average cost', 1);('ol', 1);('wherelis theaverage number steps', 1);('generate synthon approaches generallyrequire', 1);('full scan reactant dataset', 1);('scalability largersynthon databases', 1);('constructing', 1);('prex tree cost', 1);('oln', 1);('wherenis sizeof synthon need construct tree reusedfor', 1);('subsequent generation tasks2 method constrains 2d topological structure molecules 3dcoordinates', 1);('need building 3d fragment database', 1);('previous workss7s8such approachesmay', 1);('technical issues', 1);('3d conformers signicantlyincrease size fragment dataset', 1);('dataset contains largeexible structures', 1);('conformation fragment', 1);('conformation isolation', 1);('inaccurate resultswhen fragment', 1);('practical issues need', 1);('multiple ways generate molecular structure', 1);('complexity computational cost', 1);('previous workss4s6whichuses depthrst', 1);('generate molecules way molecular graph correspond', 1);('atom generation', 1);('model exible', 1);('pointsfor generation', 1);('previous works42', 1);('method constrain chemical space', 1);('ring conformation synthon dataset', 1);('illustrative example', 1);('alleviate problem wes7adopt', 1);('ringgeneration scheme allocates size location ofthe ring structures', 1);('previous section14', 1);('network', 1);('architecturein section', 1);('description neural network architecture rstdescribe inputs', 1);('network show inputs embeddedbefore', 1);('detail architecture neural', 1);('generatethe action step', 1);('madebased', 1);('policy network141', 1);('input', 1);('featuresthe model', 1);('synthons inputs', 1);('shape pharmacophore information', 1);('generation tasksgraph inputs', 1);('synthons theintermediate synthon structures', 1);('generation trajectories actsas', 1);('representation molecular graphs', 1);('similar concept sentencein', 1);('nlptasks', 1);('action thesequence corresponds atoken word inthe sentencethe', 1);('current step id t2 action', 1);('action type actt type newbonds', 1);('node action', 1);('index idt', 1);('step atom', 1);('element type elt', 1);('formal charge fctand number', 1);('explicit hydrogens neht', 1);('node act target ring closureis', 1);('rt4 ring', 1);('size ring rst', 1);('target ring closure rttin addition information', 1);('previous works4those frames severalfunctionalities1 coordinates', 1);('frames spherical', 1);('local frames correspond bond lengths bond angles andtorsion angles2 frames', 1);('modules communicate 3d information betweenthe tokens3 frames', 1);('relative 3d positional embeddings tokensto', 1);('belowbesides input', 1);('action pair asrelative', 1);('increase performance model pair', 1);('include1 topological distance', 1);('atoms step topttprime2 distance', 1);('generationtrajectory treettprime recall descriptions section', 1);('s123', 1);('relative 3d positions', 1);('action pair atatprime rst calculate displacement theorigins frame transform', 1);('local coordinateframe', 1);('ais9pharmacophore inputs input pharmacophore model', 1);('individual pharmacophore', 1);('alignits9eachpharmacophore', 1);('pcontains information type ptp radius prp use theeuclidean distances pdppprime pharmacophore pairs ppprimeas', 1);('relative positional embeddingsin decoder need communicate pharmacophore model thesynthon structure', 1);('feed model', 1);('information the3d relationship pharmacophoreaction pair1 position pharmacophore local', 1);('eachaction xpt2 direction pharmacophore', 1);('hbds hbas', 1);('local coordinatesystems', 1);('action nptshape inputs shape input originate', 1);('active ligands', 1);('fromthe target pocket', 1);('panthers10in', 1);('theinput shape', 1);('3d spheres', 1);('previous models', 1);('3dcnn encode shapeinformations11this method equivariant induces', 1);('additional computational costsin comparison', 1);('se3', 1);('equivariant representation for3d shapes', 1);('coecients input shape', 1);('3d spheres wecan', 1);('3d scalar function', 1);('grant', 1);('nsummationdisplayi1piexpixxi2where', 1);('xiis location sphere piandiare parameters', 1);('radiusof sphere dene function', 1);('center thes10spheres xc1nsummationtextni1xi function', 1);('asfx summationdisplaynlmcmnlzmnlxwherezmnlxare 3d', 1);('polynomialss13in work use', 1);('series withn9 functions generalizations', 1);('2d space andact orthogonal basis 3d functions', 1);('ball radius', 1);('additionallythose', 1);('coecients ccmnlnlmchanges equivariant manner rotation', 1);('rso3is', 1);('function ffprimex fr1x summationdisplaynlmsummationdisplaymprimerlmmprimecmprimenlzmnlxwhererlmmprimeare matrices', 1);('rotate coecients function fthose matrices', 1);('ivanic', 1);('als14the representation shape', 1);('themodel rotate local', 1);('frames action xctct concatenate itwith action', 1);('words shape information', 1);('transformersimilar positional', 1);('embedding', 1);('layersseveral types', 1);('input information', 1);('lookup', 1);('trainable parameters type layer', 1);('atombond pharmacophore types', 1);('topological distances', 1);('full list inputsincludesacttnbtteltfctnehtbtrtrsttopttprimetreettprime andptp2', 1);('positional', 1);('sine cosine functionss15this type', 1);('transformer models', 1);('data work wes11use', 1);('time position', 1);('full list includestidxtrttxttprimepdppprimextpandxct3 inputs', 1);('continuous representations input model asis includesprpnpt ctafter inputs', 1);('token action pharmacophore', 1);('token pairwe concatenate input information vector use linear layer project inputsto', 1);('transformer inputs', 1);('size ofthe dimension', 1);('ffor', 1);('fprimefor', 1);('token pair work', 1);('fprimef2and', 1);('f143', 1);('transformer architecturethetransformerisresponsibleforprocessingtheinputfeaturestogenerateastateembeddingat step', 1);('policy network', 1);('multiple encoders', 1);('responsible processing dierentinputs decoder', 1);('generate state embedder decoder encoders', 1);('attention layers tokenwisedense layer attention', 1);('residue blocksattention layers', 1);('types attention layers', 1);('work rst', 1);('dotproduct attentionsdpas15with', 1);('additional relative positional biasgiven', 1);('source sequence hsilsi1 target sequence htilti1 thesourcetarget', 1);('token pairs hpijj1l si1l attention layer performs', 1);('operationsto calculate output', 1);('hprimeilti1for target tokenkhjvhjhh1', 1);('phpijs12ahij softmax j1dqhikhjbhijhprimei', 1);('outlssummationdisplayj1ahijvhjlssummationdisplayj1ahijzhijhh1wherei 1ltj 1lsh 1hhdenotes number attention heads', 1);('work dis thedimension query key value vector', 1);('dfh operatorrepresents concatenation', 1);('sideof equationsthe', 1);('type attention invariant point attention', 1);('alphafold2s16similar sdpa', 1);('rst calculate', 1);('queries target sequenceas', 1);('keys values source sequencekhjvhjhh1', 1);('phpijwherei 1ltj 1lsdierent', 1);('calculates keys queries values', 1);('3d pointsvectorkphivector vphih1hp1p', 1);('linear3dkvhsivector', 1);('linear3dqhtjwherei', 1);('1ltj 1lswherepis number points attention head', 1);('workthose points', 1);('system asvectorkprimephjrsjvectorkphjosjvectorvprimephjrsjvector vphjosjvectorqprimephirtivector qphiotis13wherei 1ltj 1lsh 1h p 1pwhereotirtilti1andosirsilsi1are', 1);('source andtarget tokens', 1);('attention', 1);('asahij softmax jwl1dqhikhjbhijhwc2psummationdisplayp1vectorqprimephivectorkprimephj2wherei 1ltj 1lsh 1hin whichwlradicalbig13andwcradicalbig29p values', 1);('calculate outputfeaturesfhilssummationdisplayj1ahijvhjfhilssummationdisplayj1ahijzhijvectorfhpi', 1);('rti1lssummationdisplayj1ahijvector', 1);('outfhifhivectorfphipp1hh1wherei 1lth 1h p 1pnote', 1);('original implementation', 1);('norm vectorfhpiin input linear projection', 1);('dierent situations thetransformer network encoder', 1);('previous synthons uses', 1);('decoder selfattention layers outerattention layers', 1);('encoder forpharmacophores decoder outerattention layers pharmacophores', 1);('sdpathe', 1);('layers consist', 1);('dense layerseach normalizationactivationlinear architecture work use layer normalizations17and', 1);('elus18as', 1);('activation units number', 1);('bes142ftransformer layers attention layers', 1);('encoder decoder networks transformer layerin encoder', 1);('attention layer', 1);('layer transformer layerin decoder', 1);('attention layers', 1);('selfattention outerattention', 1);('layer attention', 1);('residualblocksencoders decoders transformer network', 1);('multiple', 1);('form encoder decoders unconditional generation tasks', 1);('6blocks encoder', 1);('blocks decoder structurebasedgenerationtasks themodelalsoreceivesshapeandpharmacophorebasedinformation whichuses', 1);('encoder decoder layers processing shallow conguration', 1);('unconditional generation tasks way', 1);('dierent network scales conguration encoder decoder uses3 blocks transformer layerstwo versions geometric transformers', 1);('work unconditionaltransformer', 1);('access ability method generate druglike geometricallyvalid molecules', 1);('synthesizability conditional', 1);('userprovidedpharmacophores shapes extract inputs', 1);('rollout policy acceleratemcts', 1);('sbdd', 1);('problems144 policy', 1);('transformer network policy network', 1);('generate action', 1);('architecture thisnetwork need rst dene action space', 1);('types decisions need', 1);('ateach step generation rst', 1);('relates topological structure', 1);('type action', 1);('new atom bond size ofthe', 1);('new ring etc', 1);('relates 3d molecular structure positionof', 1);('new atomfor topological decisions iterate synthon dataset', 1);('synthon structures result topological actionspaceatopo 3d actions', 1);('step thelocal spherical', 1);('node r discretizerand', 1);('example rst', 1);('intervals 2n1i2n1i1i 1n', 1);('value interval', 1);('crude achievefurther precision crudeis', 1);('n2smaller', 1);('chunks nd', 1);('similar procedures', 1);('action asa atoporcruderrenedcruderenedcruderenedwhereatopoatoporcrudecrudecrude1n 1rrenedrenedrened1n 2in work', 1);('n1is', 1);('n2to', 1);('task policy network toparametrize distribution', 1);('neural network pah whereis parameterof network state', 1);('model joint distribution ofdiscrete variables factorize', 1);('autoencoderfor density estimation model architecture network contains', 1);('layers 630hidden units layerthe general idea policy network', 1);('similar previous version', 1);('deepligs16builders4the', 1);('major dierence use', 1);('action space', 1);('previously', 1);('continuous distributionof atom positions faces numerical issues', 1);('address issueshowever', 1);('noise 3d coordinates reduces accuracy model', 1);('twostep discretization processwhich ensures precision distribution', 1);('numerical instabilities incontinuous distributions15', 1);('dataset', 1);('network training151', 1);('training', 1);('unconditional modelwe use dataset', 1);('global stock training', 1);('astepwise procedure', 1);('random building block', 1);('thedataset step', 1);('possible reactions', 1);('lters appliedto', 1);('lipinskis', 1);('ro5s192 vebers', 1);('pains', 1);('qeds22threshold', 1);('andthe rest', 1);('3d conformers molecules', 1);('molecules 3d space', 1);('stable conformers', 1);('molecular structures', 1);('transformedinto generation trajectories train unconditional transformerthe network', 1);('pytorch adam', 1);('model optimizations23s17withalinearlearningratewarmupofoneepochto0001 followedbyanexponentiallearningrate decay decay rate', 1);('decay frequencies', 1);('batch size', 1);('gpus', 1);('days completeto train shape', 1);('model dataset inputoutputpairs', 1);('pharmacophore models andshapes 3d ligands', 1);('datasets24we use', 1);('thedata source', 1);('ligand diversity contains druglike ligands alsometabolites peptides fragments types ligands lack druglikeness arestill', 1);('pharmacophore extraction interaction analysis way wecan increase diversity pharmacophore shape inputs', 1);('notuse protein structure bioactivity values', 1);('pharmacophoresan overall', 1);('pharmacophores shapes', 1);('pharmacophores lter good', 1);('formthe training', 1);('974917124563d alignment operations dueto time cost utilize approach', 1);('sequential ltering1', 1);('similarity calculation', 1);('usrcat', 1);('ngerprints lter thetop', 1);('similar molecules pharmacophore shape query', 1);('sinceusrcat', 1);('3d alignment', 1);('gpu2', 1);('3d alignments 1000012456pairs molecules andqueries', 1);('3d shape shapes', 1);('combination 3d', 1);('rdkit pca', 1);('onthe point', 1);('principle axes axes', 1);('form initials18pose', 1);('candidate poses', 1);('180around axis', 1);('optimization process', 1);('tune rotation translation achievethe', 1);('shapes alignment process', 1);('pytorch', 1);('shape', 1);('pose andthe top', 1);('pharmacophoreshape query3', 1);('enrich moleculequery pairs', 1);('similar molecules pharmacophore shapebasedquerythe', 1);('creates dataset', 1);('124560inputoutput pairs model training training conditional model use', 1);('unconditional model base model', 1);('pharmacophore shaperelatedlayers tail transformer', 1);('rate decay', 1);('steps hyperparameters training theconditional model', 1);('train unconditional counterpart16', 1);('tree searchmonte', 1);('carlo', 1);('technique reinforcement learning', 1);('search tree thiswork wecombinemctswiththepharmacophoreandshapeconditionedtransformerforthedesign', 1);('pocket order search promisingmolecular structures', 1);('lookahead tree', 1);('tand', 1);('tusingfour', 1);('steps selection expansion simulation backpropagation', 1);('usesa variant', 1);('suit 3d moleculegeneration tasks section rst describe data structure lookahead trees19t', 1);('specify details thehyperparameters', 1);('intermediate state molecule generation edge representingan action', 1);('custommodications data structure nodes edges1', 1);('edges', 1);('topological 3d actions', 1);('molecular graph ateach step 3d action', 1);('section 144note edge stores value', 1);('torsion angle', 1);('thisis', 1);('bond lengths rand bond angles', 1);('bondtypes ring sizes', 1);('topological actions2 torsion angles', 1);('form crudein way nodes', 1);('tnow', 1);('molecule structures', 1);('similar 3dconformations', 1);('similar eect', 1);('intermediate states', 1);('thetorsion ngerprintat step', 1);('consecutively1 selection operation chooses', 1);('promising state tree', 1);('value function', 1);('mentss25and', 1);('e2w empirical exponentialweight', 1);('generate selection policy', 1);('acluster states topological structure', 1);('similar 3d conformation', 1);('werandomly', 1);('states cluster2 expansion operation enumerates', 1);('outgiven state practice', 1);('action space 3dgenerative model', 1);('small subset actions', 1);('bythe model', 1);('observation rst', 1);('multiple independent samplings20of actions', 1);('transformer cluster actions basedon topological action torsion angle', 1);('procedure issimilar', 1);('branches search tree', 1);('small probability chosenby transformer3 simulation operation', 1);('full rollout', 1);('selectedstate results', 1);('expansion operation', 1);('rollout actsas form leaflevel', 1);('subsequent actions', 1);('ateach rollout', 1);('instability thetree', 1);('rollout uses ashape', 1);('generative modelwhen', 1);('soft version thesmina score reward functionrm softplussm summationtext3i1softplusssi2wheremis', 1);('molecule si 123are synthons fragments composedof molecule', 1);('sis smina', 1);('minimization andsoftplusx ln1 exp x', 1);('adding', 1);('softplusto equation', 1);('large penaltiesfrom clashes pocket making reward function softer4', 1);('estimates edge', 1);('following ments', 1);('softbellman backup asthe operator update', 1);('valuesthe number rollout steps case study', 1);('gpuresources', 1);('treelevel rootlevel leaflevel parallelism', 1);('selections21an overall', 1);('case study expansion', 1);('fullaction space', 1);('states rollouttherearetwomajorparameterscontrollingthebalancebetweenexplorationandexploitationin', 1);('mentss25the', 1);('temperature parameter exploration parameter epsilon1in', 1);('e2w inthis', 1);('work 025andepsilon1', 1);('program uses', 1);('nvidia', 1);('3070graphics card', 1);('cpu', 1);('model', 1);('evaluationseveral evaluations', 1);('different aspects171 unconditional generation tasksfor unconditional model', 1);('generate druglike moleculeswith highquality 3d structures end dataset', 1);('targetof comparison', 1);('evaluation metrics employed1', 1);('metrics', 1);('molecular properties molecule series 2d or3d properties', 1);('logp qed', 1);('number ofhydrogen bond donors acceptors number', 1);('rotatable bonds total polar solvent accessible surface areas radius gyration distributions ofthose properties', 1);('molecules assembledmolecules test', 1);('standard deviation values', 1);('property dataset', 1);('standard deviation values fora quantitative measurement', 1);('wradicalbig122', 1);('mathematically', 1);('approximations oftwo distributions2 quantitative measurement', 1);('thedruglike chemical space', 1);('mmds27betweengenerated', 1);('2d morgan 3d', 1);('usrcatngerprints mmd', 1);('dierences distributions', 1);('previous works evaluation molecule generative modelss4s28mmdcan', 1);('followsmmd2uxy 1mm1summationdisplayinegationslashjkxixj 1nn1summationdisplayinegationslashjkyiyj2mnsummationdisplayijkxiyjwherexximi1andyyini1are', 1);('kis kernelfunction', 1);('toevaluatethequalityof3dstructures', 1);('similar previous works4we', 1);('distributionof torsion angles', 1);('molecules environments', 1);('als29thedierence torsion angle distributions', 1);('thecosine values torsion angle dierence kernel function', 1);('mmd4', 1);('access quality', 1);('conformers model optimize', 1);('force eld calculate', 1);('valuebetween conformers optimization', 1);('context themodels performance', 1);('evaluation conformers', 1);('etkdgs30method', 1);('conformation optimizations23172', 1);('generation taskswhen', 1);('generation taskswe', 1);('enrich molecules', 1);('conditional rollout policy', 1);('results fastera series ablation studies', 1);('termsof benet', 1);('scoresfor molecules', 1);('scores rstmove', 1);('molecules protein pocket', 1);('local relaxation eachmolecule', 1);('forceeld redock', 1);('intothe target pocket', 1);('sminato', 1);('access benet conditional rollout policy', 1);('studies performed1', 1);('wedeterminewhethertheconditionalmodelcanachieveenrichmentinpharmacophoreandshapecomparedwithitsunconditionalcounterpart thisquestioncanbeansweredby', 1);('distribution shape pharmacophore similarity', 1);('molecules input queries2', 1);('extra conditional inputs', 1);('fastersearch speeds end ablation studies', 1);('conditional inputs rollout policy', 1);('step recordthe reward value', 1);('theconditional rollout policy', 1);('rewards faster2', 1);('supplementary figuress24figure s1', 1);('reactant building block dataset synthons25figure', 1);('special treatment', 1);('reactants synthons thereaction involves ring formations26figure', 1);('representation molecule generation process', 1);('nite state machinefrom gure', 1);('ring target state', 1);('ring state chaingeneration', 1);('chains state', 1);('3d molecule', 1);('deepligbuilders28figure s5 issues', 1);('ring generation synthon dataset', 1);('generation scheme alleviate problem athe', 1);('original synthondataset structures', 1);('molecules bthe', 1);('ring removedfrom dataset', 1);('aresult model', 1);('attempt generate', 1);('rings generation', 1);('due constraints', 1);('available synthons', 1);('chowever ring size', 1);('itsstructures model', 1);('synthon constraints resultingin molecule structures', 1);('s6 examples', 1);('unconditional transformeralong building blocks', 1);('reactions synthesize moleculess30figure', 1);('s7', 1);('distribution 2d 3d molecular properties', 1);('blue testset grey', 1);('red molecules 2d properties', 1);('amolecularweight blogp cqed dthe number hydrogen bond acceptors', 1);('ethe numberof hydrogen bond donors fthe number', 1);('3d properties includesgthe total', 1);('solvent accessible surface area', 1);('sasa', 1);('hpolar solvent accessiblesurface areas', 1);('polarsasa', 1);('ithe radius gyrations31figure', 1);('s8', 1);('tsne visualization distribution amorgan ngerprint busrcat ngerprint', 1);('blue dots', 1);('molecules grey dots', 1);('test setmolecules', 1);('red dots', 1);('s9', 1);('values relaxation', 1);('mmff94s bluemolecules', 1);('grey', 1);('molecules conformations', 1);('rdkits32figure s10', 1);('structure search tree rst synthon', 1);('btksatpbinding', 1);('nodes visit', 1);('synthon structures', 1);('important pharmacophore', 1);('leftmost example shows state', 1);('unfavorable anchor position result state', 1);('qvaluess33figure s11', 1);('bthe part', 1);('extract pharmacophore shape seed molecule generation', 1);('pharmacophoreand shape extractionfigure', 1);('3b themodel', 1);('compound', 1);('potent inhibitor', 1);('thenad pocket', 1);('bthe pharmacophore', 1);('modeof molecule', 1);('seed location molecule growthfigure', 1);('7b themodel', 1);('supplementary', 1);('summary dierent hyperparameter congurations', 1);('bbs', 1);('lr', 1);('variant', 1);('3d pairembeddingwidthfdepthdecay frequencystepsnoiseprobabilitynoisescalebuildingblockdefaultcongurationcheck check', 1);('globalbbs eu', 1);('stock check check', 1);('eucomprehensivecatalogcheck', 1);('comprehensive3d', 1);('globaldropped', 1);('3d pairembeddingcheck', 1);('globalscale narrow', 1);('globalshallow', 1);('globallr fast', 1);('globals36modelarchitecturetrainingparametergenerationparameterslow', 1);('globalnoise', 1);('high noiseprobabilitycheck check', 1);('noiseprobabilitycheck check', 1);('globalhigh', 1);('distribution 2d molecular properties', 1);('mw logp hba hbd rot qedmean', 1);('018default conguration', 1);('003eu stock', 1);('3d pairembedding41491', 1);('003narrow network', 1);('004shallow network', 1);('003fast learning ratedecay41136', 1);('004slow learning ratedecay41353', 1);('003high noise probability', 1);('003s38model variant', 1);('mw logp hba hbd rot qedlow', 1);('noise probability', 1);('005large noise scale', 1);('test', 1);('distribution 3d molecular properties', 1);('gyrationmean std wd', 1);('03default conguration', 1);('005eu stock', 1);('003comprehensive catalog', 1);('002narrow network', 1);('003shallow network', 1);('002fast learning rate decay', 1);('004slow learning rate decay', 1);('005high noise probability', 1);('002low noise probability', 1);('015large noise scale', 1);('s40model', 1);('s4 quantitative', 1);('measurement quality', 1);('samples rst', 1);('tanimoto usrcat', 1);('column shows 2d 3d', 1);('values whichmeasures ability network', 1);('model distribution chemical space nal column containsthe average', 1);('forceeld row', 1);('dierent hyperparameterconguration', 1);('anydruglikeness lteringmodel variant', 1);('diversity2d diversity3d mmd2d mmd3d mean rmsdrandomly', 1);('etkdgdefault', 1);('0692eu stock', 1);('0725comprehensive catalog', 1);('0718narrow network', 1);('0716shallow network', 1);('0707fast learning rate decay', 1);('0734slow learning rate decay', 1);('0672high noise probability', 1);('0685low noise probability', 1);('0795large noise scale', 1);('0685small noise scale', 1);('altmann kh schneider g jacoby e renner collection robust organic synthesis reactionsfor silico molecule', 1);('goldberg', 1);('f w', 1);('kettle j g kogej perry', 1);('tomkinson n p designingnovel', 1);('compound quality', 1);('drugdiscovery', 1);('london n miller r krishnan uchida k irwin j j eidam gibold', 1);('cimermani p bonnet r shoichet', 1);('k taunton j covalent', 1);('large libraries discovery chemical probes', 1);('nature', 1);('biology', 1);('ahn chen', 1);('wang', 1);('song l', 1);('spanning', 1);('graph generation formolecules', 1);('learning representationss6 li zhang', 1);('powers yu h h suriana p dror r fragmentbased ligand generationguided geometric deep learning proteinligand structure', 1);('adams k coley', 1);('equivariant shapeconditioned generation', 1);('moleculesfor ligandbased drug', 1);('design arxiv 2022s43s9', 1);('taminau j thijs g winter h pharao pharmacophore', 1);('alignment optimization journal', 1);('molecular graphics modelling', 1);('kurkinen ltti pentikinen postila p', 1);('docking', 1);('negative imagebased rescoring', 1);('skalic jimenez j sabbadin fabritiis g shapebased generative modeling', 1);('grant j gallardo pickup', 1);('fast method molecular shape comparison', 1);('simple application', 1);('description molecular shape journal ofcomputational chemistry', 1);('wang q birod k angioni', 1);('grsch geppert schneider p rupp mschneider g spherical harmonics coecients ligandbased virtual screening', 1);('inhibitors plos one', 1);('ivanic j ruedenberg k rotation matrices real spherical harmonics directdetermination recursion', 1);('physical chemistry', 1);('vaswani shazeer n parmar n uszkoreit j jones', 1);('gomez nkaiser', 1);('polosukhin attention need', 1);('jumper j evans r pritzel', 1);('figurnov ronneberger tunyasuvunakool k bates r', 1);('potapenko bridgland meyer ckohl ballard j cowie romeraparedes', 1);('nikolov jain radler j', 1);('petersen reiman clancy e zielinski steinegger mpacholska berghammer bodenstein silver vinyals senior ws44kavukcuoglu k kohli p hassabis highly', 1);('accurate protein structure predictionwith', 1);('alphafold nature', 1);('ba j', 1);('kiros j r hinton g e layer normalization', 1);('clevertda unterthinert hochreitersfastandaccuratedeepnetworklearning exponential linear units elus', 1);('lipinski', 1);('lombardo', 1);('dominy', 1);('b w', 1);('feeney p j experimental', 1);('computational approaches', 1);('solubility permeability drug discovery anddevelopment settings1pii', 1);('original article', 1);('s0169409x96004231', 1);('advanced drug delivery reviews', 1);('advanceddrug delivery reviews', 1);('veber', 1);('johnson r cheng hy smith', 1);('r ward k', 1);('kopple k dmolecular properties inuence oral bioavailability drug candidatesjournal medicinal chemistry', 1);('baell j walters chemistry', 1);('chemical con artists foil drug discovery', 1);('nature2014513', 1);('kingma p ba j adam method stochastic optimization', 1);('arxiv 2014httpsarxivorgabs14126980s24', 1);('wang r fang x lu wang pdbbind database collection bindinganities proteinligand complexes known threedimensional structuresjournal medicinal chemistry', 1);('chaslot g j', 1);('winands h herik h j', 1);('parallel montecarlo', 1);('proceedings', 1);('computers', 1);('cg20085131', 1);('kerneltwosample test journal', 1);('schrferc schulzgascht ehrlichhc gubaw rareym stahlmtorsionangle preferences druglike', 1);('riniker landrum g', 1);('informed distance geometry', 1);('weknow improve conformation generation', 1);